Phyteau Company
Phyteau is developing a new class of therapeutics for diabetes, obesity, weight-loss, and related metabolic condition like NAFLD and NASH. The company's therapeutics work in the intestines where they trigger key cellular receptors causing the release of therapeutic levels of key metabolic hormones, like GLP-1, PYY and CCK. The hormones work naturally and safely to control blood sugar, appetite, food intake, and metabolism. The company continues to develop new solutions to help people around the world suffering from metabolic diseases. Phyteau was founded on 2017 and is headquartered in Santa Fe, New Mexico.
Technology:
Cancer
Industry:
Geroscience
Headquarters:
Santa Fe, New Mexico, United States
Zip:
1-10
Founded Date:
2017-01-01
Employees Number:
1-10
Funding Status:
Seed
Acquisitions Number:
2
Investors Number:
2
Total Funding:
$1M to $10M
Estimated Revenue:
$1M to $10M
Last Funding Date:
Seed
Last Funding Type:
info@phyteau.co
Register and Claim Ownership